Kim Hyun-Ju, Yoon Hye-Jin, Kim Bo Kyung, Kang Woo Youl, Seong Sook Jin, Lim Mi-Sun, Kim Shin-Yoon, Yoon Young-Ran
Department of Molecular Medicine, Cell and Matrix Research Institute, Clinical Trial Center, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University School of Medicine, Daegu, Korea.
College of Pharmacy, Yeungnam University, Gyeonsan, Korea.
J Cell Physiol. 2016 Apr;231(4):844-51. doi: 10.1002/jcp.25133. Epub 2015 Sep 1.
G protein-coupled receptor 120 (GPR120) plays an important role in the regulation of inflammation and lipid metabolism. In this study, we investigated the role of GPR120 in osteoclast development and found that GPR120 regulates osteoclast differentiation, survival and function. We observed that GPR120 was highly expressed in osteoclasts compared to their precursors, bone marrow-derived macrophages (BMMs). Activation of GPR120 by its ligand GW9508 suppressed receptor activator of NF- κB ligand (RANKL)-induced osteoclast differentiation and the expression of nuclear factor of activated T cells c1 (NFATc1), a key modulator of osteoclastogenesis. GPR120 activation further inhibited the RANKL-stimulated phosphorylation of IκBα and JNK. In addition to osteoclast differentiation, GPR120 activation increased the apoptosis of mature osteoclasts by inducing caspase-3 and Bim expression. Activation of GPR120 also interfered with cell spreading and actin cytoskeletal organization mediated by M-CSF but not by RANKL. Coincident with the impaired cytoskeletal organization, GPR120 activation blocked osteoclast bone resorbing activity. Furthermore, knockdown of GPR120 using small hairpin RNA abrogated all these inhibitory effects on osteoclast differentiation, survival, and function. Together, our findings identify GPR120 as a negative modulator of osteoclast development that may be an attractive therapeutic target for bone-destructive diseases. J. Cell. Physiol. 231: 844-851, 2016. © 2015 Wiley Periodicals, Inc.
G蛋白偶联受体120(GPR120)在炎症和脂质代谢调节中发挥重要作用。在本研究中,我们调查了GPR120在破骨细胞发育中的作用,发现GPR120调节破骨细胞的分化、存活和功能。我们观察到,与破骨细胞前体骨髓来源的巨噬细胞(BMM)相比,GPR120在破骨细胞中高表达。其配体GW9508激活GPR120可抑制核因子κB受体激活剂配体(RANKL)诱导的破骨细胞分化以及活化T细胞核因子c1(NFATc1)的表达,NFATc1是破骨细胞生成的关键调节因子。GPR120激活进一步抑制RANKL刺激的IκBα和JNK磷酸化。除破骨细胞分化外,GPR120激活通过诱导半胱天冬酶-3和Bim表达增加成熟破骨细胞的凋亡。GPR120激活还干扰了由巨噬细胞集落刺激因子(M-CSF)介导而非RANKL介导的细胞铺展和肌动蛋白细胞骨架组织。与细胞骨架组织受损一致,GPR120激活阻断了破骨细胞的骨吸收活性。此外,使用小发夹RNA敲低GPR120消除了所有这些对破骨细胞分化、存活和功能的抑制作用。总之,我们的研究结果确定GPR120是破骨细胞发育的负调节因子,可能是骨破坏性疾病有吸引力的治疗靶点。《细胞生理学杂志》231: 844 - 851, 2016年。© 2015威利期刊公司